Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
BioTime, Inc. (NY: BTX)
4.230 USD  +0.040 (+0.95%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 170,813
Open 4.210
Bid (Size) 4.100 (200)
Ask (Size) 4.390 (100)
Prev. Close 4.190
Today's Range 4.200 - 4.340
52wk Range 2.670 - 5.068
Shares Outstanding 55,728,781
Dividend Yield N/A
Featured News
More News
Are stem-cell stocks a good buy?
July 13, 2011
After years of being swatted about like ping-pong balls, are stem-cell stocks now a good buy for investors? Read More
category Biotechnology , BCLI , ASTM , and 32 more.
from MarketWatch
Endo, Celgene lead drug stocks lower
December 08, 2009
Drug stocks retreat with the broader market, led by biotech groups Endo Pharmaceuticals and Celgene. Read More
category Market News , BTIM , Biotechnology , and 9 more.
from MarketWatch

More News
Read More
BioTime CEO Dr. Michael West to Present at USC Minisymposium: Musculoskeletal Development and Repair
May 20, 2013
from Business Wire News Releases
BioTime Appoints Franklin Berger to Board of Directors
May 14, 2013
from Business Wire News Releases
BioTime (BTX) Subsidiary Cell Cure Neurosciences Receives $1.5 Million Grant from Israeli Agency
May 14, 2013
category Stocks
from TransWorldNews Current Releases
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.5 Million Grant from Israel’s Office of the Chief Scientist
May 13, 2013
from Business Wire News Releases
BioTime Announces First Quarter 2013 Financial Results and Recent Corporate Accomplishments
May 10, 2013
from Business Wire News Releases
PDL BioPharma Announces First Quarter 2013 Financial Results
May 09, 2013
from PR Newswire
BioTime and Subsidiary LifeMap Sciences Announce Release of Enhanced LifeMap BioReagents™ Portal Offering Additional PureStem™ Human Progenitor Cells Including Those for Diabetes Research
May 07, 2013
from Business Wire News Releases
PDL BioPharma Appoints Peter Garcia as Chief Financial Officer
April 30, 2013
from PR Newswire
Could We Be in a Blossoming Market?
April 30, 2013
category Henry McCusker
from Bio-Wire.Com
LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.10
April 30, 2013
from Business Wire News Releases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
Random Thoughts: A Signal That Bears Watching
Todd Harrison
2
Apple: Stock Charts Show It May Be Ready for a Reaction Rally
Jason Haver
3
Random Thoughts: The Chasm Between Stocks and Commodities Continues to Widen
Todd Harrison
4
Xbox One and PS4: New Consoles Are Nice, but New Gamers Would Be Even Better
Michael Comeau
5
1929, 1987, and 2013: Three of a Kind?
Jeffrey Cooper

Financial Product Guide